Galmed Pharmaceuticals (EOCN) Total Debt (2013 - 2026)
Galmed Pharmaceuticals' Total Debt was $834,000 in Q2 2026, down 20.7% from $1.05 million a year earlier but up 134.9% from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Total Debt (2013 - 2026) Analysis & Trends
At the end of FY2025, Total Debt at Galmed Pharmaceuticals came in at $842,000, up 83.4% from FY2024.
- Total Debt shows a five-year compound annual growth rate of -2.7% (FY2020 to FY2025).
- In earlier years, Total Debt was $459,000 in FY2024 (-47.3%), $871,000 in FY2023 (+63.1%), $534,000 in FY2022 (-47.0%) and $1.01 million in FY2021 (+4.3%).
- Quarterly Total Debt has moved between $282,000 (Q3 2022) and $1.17 million (Q3 2024) over five years.
- Compared with a year earlier, Total Debt was higher in four of the last eight quarters, with growth averaging 34.4%.
- The best year-over-year quarter for Total Debt over five years was Q2 2025 (growth of 199.7%); the worst was Q3 2022 (a decline of 74.7%).
- Per Business Quant data, EOCN's Total Debt in the three quarters before Q2 2026 was $355,000 (Q1 2026), $842,000 (Q4 2025) and $798,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Galmed Pharmaceuticals | 422,361.40 | 422,361.40 | - | 834,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 834,000.00 |
| Mar 31, 2026 | 355,000.00 |
| Dec 31, 2025 | 842,000.00 |
| Sep 30, 2025 | 798,000.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 499,000.00 |
| Dec 31, 2024 | 459,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 351,000.00 |
| Mar 31, 2024 | 382,000.00 |
| Dec 31, 2023 | 871,000.00 |
| Sep 30, 2023 | 617,000.00 |
| Jun 30, 2023 | 583,000.00 |
| Mar 31, 2023 | 535,000.00 |
| Dec 31, 2022 | 534,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Jun 30, 2022 | 640,000.00 |
| Mar 31, 2022 | 812,000.00 |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 1.12 Mn |
API Access
Galmed Pharmaceuticals Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();